Replimune lands commercial chief after hard-fought approval; Neumora's Paul Berns sheds CEO title

→ Fresh off a new accelerated approval for its melanoma therapy, Replimune has named Michelle DiNapoli as chief commercial officer, effective Aug. 18. DiNapoli formerly worked at Genentech and led ...